On the origin of urinary renin: A translational approach

Hypertension

Volumn 67, Issue 5, 2016, Pages 927-933

  Roksnoer, Lodi C W ^a   Heijnen, Bart F J ^b   Nakano, Daisuke ^c,d   Peti Peterdi, Janos ^c   Walsh, Stephen B ^e   Garrelds, Ingrid M ^a   Van Gool, Jeanette M G ^a   Zietse, Robert ^a   Struijker Boudier, Harry A J ^b   Hoorn, Ewout J ^a   Danser, A H Jan ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d KAGAWA UNIVERSITY   (Japan)

^e ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

angiotensinogen; Dent disease; glomerular filtration barrier; Lowe syndrome; renin

Indexed keywords

ALBUMIN; ANGIOTENSINOGEN; CREATININE; CYTOCHROME P450 1A1; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXORUBICIN; HYDRALAZINE; LOSARTAN; MEGALIN; PRORENIN; RENIN; ALBUMINOID;

ADULT; ALDOSTERONE URINE LEVEL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DENT DISEASE; ENZYMURIA; FLUID INTAKE; GLOMERULAR FILTRATION BARRIER; GLOMERULUS FILTRATION; HUMAN; HYPERTENSION; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; LOWE SYNDROME; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; PROXIMAL TUBULAR REABSORPTION; RAT; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; DISEASE MODEL; EPIDEMIOLOGY; GLOMERULUS; GLOMERULUS FILTRATION RATE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TRANSLATIONAL RESEARCH; URINALYSIS; URINE; YOUNG ADULT;

ALBUMINS; ANGIOTENSINOGEN; ANIMALS; DENT DISEASE; DISEASE MODELS, ANIMAL; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY GLOMERULUS; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; OCULOCEREBRORENAL SYNDROME; RATS; RENIN; RENIN-ANGIOTENSIN SYSTEM; SAMPLING STUDIES; TRANSLATIONAL MEDICAL RESEARCH; URINALYSIS; YOUNG ADULT;

EID: 84959278395     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.115.07012     Document Type: Article

References (41)

1. Graham RC Jr, Karnovsky MJ, Glomerular permeability. Ultrastructural cytochemical studies using peroxidases as protein tracers. J Exp Med 1966 124 1123 1134
2. Alge JL, Karakala N, Neely BA, Janech MG, Tumlin JA, Chawla LS, Shaw AD, Arthur JM, SAKInet Investigators Urinary angiotensinogen and risk of severe AKI. Clin J Am Soc Nephrol 2013 8 184 193
3. Alge JL, Karakala N, Neely BA, Janech MG, Tumlin JA, Chawla LS, Shaw AD, Arthur JM, SAKInet Investigators Association of elevated urinary concentration of renin-Angiotensin system components and severe AKI. Clin J Am Soc Nephrol 2013 8 2043 2052. doi: 10.2215/CJN.03510413
4. van den Heuvel M, Batenburg WW, Jainandunsing S, Garrelds IM, van Gool JM, Feelders RA, van den Meiracker AH, Danser AH, Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-Angiotensin-Aldosterone system activity and the efficacy of renin-Angiotensin-Aldosterone system blockade in the kidney. J Hypertens 2011 29 2147 2155. doi: 10.1097/HJH.0b013e32834bbcbf
5. Kobori H, Nishiyama A, Abe Y, Navar LG, Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension 2003 41 592 597. doi: 10.1161/01.HYP.0000056768.03657.B4
6. Kobori H, Alper AB Jr, Shenava R, Katsurada A, Saito T, Ohashi N, Urushihara M, Miyata K, Satou R, Hamm LL, Navar LG, Urinary angiotensinogen as a novel biomarker of the intrarenal renin-Angiotensin system status in hypertensive patients. Hypertension 2009 53 344 350. doi: 10.1161/HYPERTENSIONAHA.108.123802
7. Mills KT, Kobori H, Hamm LL, Alper AB, Khan IE, Rahman M, Navar LG, Liu Y, Browne GM, Batuman V, He J, Chen J, Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease. Nephrol Dial Transplant 2012 27 3176 3181. doi: 10.1093/ndt/gfs011
8. Verdonk K, Saleh L, Lankhorst S, Smilde JE, van Ingen MM, Garrelds IM, Friesema EC, Russcher H, van den Meiracker AH, Visser W, Danser AH, Association studies suggest a key role for endothelin-1 in the pathogenesis of preeclampsia and the accompanying renin-Angiotensin-Aldosterone system suppression. Hypertension 2015 65 1316 1323. doi: 10.1161/HYPERTENSIONAHA.115.05267
9. Yamamoto T, Nakagawa T, Suzuki H, Ohashi N, Fukasawa H, Fujigaki Y, Kato A, Nakamura Y, Suzuki F, Hishida A, Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease. J Am Soc Nephrol 2007 18 1558 1565. doi: 10.1681/ASN.2006060554
10. Roksnoer LC, Verdonk K, van den Meiracker AH, Hoorn EJ, Zietse R, Danser AH, Urinary markers of intrarenal renin-Angiotensin system activity in vivo. Curr Hypertens Rep 2013 15 81 88. doi: 10.1007/s11906-012-0326-z
11. Matsusaka T, Niimura F, Pastan I, Shintani A, Nishiyama A, Ichikawa I, Podocyte injury enhances filtration of liver-derived angiotensinogen and renal angiotensin II generation. Kidney Int 2014 85 1068 1077. doi: 10.1038/ki.2013.453
12. Matsusaka T, Niimura F, Shimizu A, Pastan I, Saito A, Kobori H, Nishiyama A, Ichikawa I, Liver angiotensinogen is the primary source of renal angiotensin II. J Am Soc Nephrol 2012 23 1181 1189. doi: 10.1681/ASN.2011121159
13. Pohl M, Kaminski H, Castrop H, Bader M, Himmerkus N, Bleich M, Bachmann S, Theilig F, Intrarenal renin angiotensin system revisited: role of megalin-dependent endocytosis along the proximal nephron. J Biol Chem 2010 285 41935 41946. doi: 10.1074/jbc.M110.150284
14. Prieto-Carrasquero MC, Harrison-Bernard LM, Kobori H, Ozawa Y, Hering-Smith KS, Hamm LL, Navar LG, Enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Hypertension 2004 44 223 229. doi: 10.1161/01.HYP.0000135678.20725.54
15. Persson F, Lu X, Rossing P, Garrelds IM, Danser AH, Parving HH, Urinary renin and angiotensinogen in type 2 diabetes: added value beyond urinary albumin? J Hypertens 2013 31 1646 1652. doi: 10.1097/HJH.0b013e328362217c
16. Kantachuvesiri S, Fleming S, Peters J, Peters B, Brooker G, Lammie AG, McGrath I, Kotelevtsev Y, Mullins JJ, Controlled hypertension, a transgenic toggle switch reveals differential mechanisms underlying vascular disease. J Biol Chem 2001 276 36727 36733. doi: 10.1074/jbc.M103296200
17. Mitchell KD, Bagatell SJ, Miller CS, Mouton CR, Seth DM, Mullins JJ, Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats. J Renin Angiotensin Aldosterone Syst 2006 7 74 86. doi: 10.3317/jraas.2006.013
18. van Kats JP, Schalekamp MA, Verdouw PD, Duncker DJ, Danser AH, Intrarenal angiotensin II: interstitial and cellular levels and site of production. Kidney Int 2001 60 2311 2317. doi: 10.1046/j.1523-1755.2001.00049.x
19. Zou LX, Hymel A, Imig JD, Navar LG, Renal accumulation of circulating angiotensin II in angiotensin II-infused rats. Hypertension 1996 27 3 Pt 2 658 662
20. Claverie-Martín F, Ramos-Trujillo E, García-Nieto V, Dent's disease: clinical features and molecular basis. Pediatr Nephrol 2011 26 693 704. doi: 10.1007/s00467-010-1657-0
21. Heijnen BF, Nelissen J, van Essen H, Fazzi GE, Cohen Tervaert JW, Peutz-Kootstra CJ, Mullins JJ, Schalkwijk CG, Janssen BJ, Struijker-Boudier HA, Irreversible renal damage after transient renin-Angiotensin system stimulation: involvement of an AT1-receptor mediated immune response. PLoS One 2013 8 e57815. doi: 10.1371/journal.pone.0057815
22. Maas RJ, Deegens JK, Wetzels JF, Permeability factors in idiopathic nephrotic syndrome: historical perspectives and lessons for the future. Nephrol Dial Transplant 2014 29 2207 2216. doi: 10.1093/ndt/gfu355
23. Nakano D, Kobori H, Burford JL, Gevorgyan H, Seidel S, Hitomi H, Nishiyama A, Peti-Peterdi J, Multiphoton imaging of the glomerular permeability of angiotensinogen. J Am Soc Nephrol 2012 23 1847 1856. doi: 10.1681/ASN.2012010078
24. Weyer K, Nielsen R, Christensen EI, Birn H, Generation of urinary albumin fragments does not require proximal tubular uptake. J Am Soc Nephrol 2012 23 591 596. doi: 10.1681/ASN.2011101034
25. Roksnoer LC, Verdonk K, Garrelds IM, van Gool JM, Zietse R, Hoorn EJ, Danser AH, Methodologic issues in the measurement of urinary renin. Clin J Am Soc Nephrol 2014 9 1163 1167. doi: 10.2215/CJN.12661213
26. Klotz S, Burkhoff D, Garrelds IM, Boomsma F, Danser AH, The impact of left ventricular assist device-induced left ventricular unloading on the myocardial renin-Angiotensin-Aldosterone system: therapeutic consequences? Eur Heart J 2009 30 805 812. doi: 10.1093/eurheartj/ehp012
27. Balcarek J, Sevá Pessôa B, Bryson C, Azizi M, Ménard J, Garrelds IM, McGeehan G, Reeves RA, Griffith SG, Danser AH, Gregg R, Multiple ascending dose study with the new renin inhibitor VTP-27999: nephrocentric consequences of too much renin inhibition. Hypertension 2014 63 942 950. doi: 10.1161/HYPERTENSIONAHA.113.02893
28. Belloc C, Gauffre A, André C, Beaune PH, Epitope mapping of human CYP1A2 in dihydralazine-induced autoimmune hepatitis. Pharmacogenetics 1997 7 181 186
29. Lumbers ER, Skinner SL, Observations on the origin of renin in human urine. Circ Res 1969 24 689 697
30. Mazanti I, Hermann KL, Nielsen AH, Poulsen K, Ultrafiltration of renin in the mouse kidney studied by inhibition of tubular protein reabsorption with lysine. Clin Sci (Lond) 1988 75 331 336
31. Kang JJ, Toma I, Sipos A, Meer EJ, Vargas SL, Peti-Peterdi J, The collecting duct is the major source of prorenin in diabetes. Hypertension 2008 51 1597 1604. doi: 10.1161/HYPERTENSIONAHA.107.107268
32. Batenburg WW, Danser AH, (Pro)renin and its receptors: pathophysiological implications. Clin Sci (Lond) 2012 123 121 133. doi: 10.1042/CS20120042
33. Nielsen AH, Hermann KL, Mazanti I, Poulsen K, Evidence for a predominant renal secretion and clearance of inactive plasma renin, studied by in vivo inhibition of protein synthesis, and inhibition of renal tubular protein reabsorption. Clin Exp Hypertens A 1988 10 1301 1303
34. Campbell DJ, Nussberger J, Stowasser M, Danser AH, Morganti A, Frandsen E, Ménard J, Activity assays and immunoassays for plasma Renin and prorenin: information provided and precautions necessary for accurate measurement. Clin Chem 2009 55 867 877. doi: 10.1373/clinchem.2008.118000
35. Reinhart SC, Norden AG, Lapsley M, Thakker RV, Pang J, Moses AM, Frymoyer PA, Favus MJ, Hoepner JA, Scheinman SJ, Characterization of carrier females and affected males with X-linked recessive nephrolithiasis. J Am Soc Nephrol 1995 5 1451 1461
36. Hosojima M, Sato H, Yamamoto K, Regulation of megalin expression in cultured proximal tubule cells by angiotensin II type 1A receptor-And insulin-mediated signaling cross talk. Endocrinology 2009 150 871 878. doi: 10.1210/en.2008-0886
37. Tojo A, Onozato ML, Kurihara H, Sakai T, Goto A, Fujita T, Angiotensin II blockade restores albumin reabsorption in the proximal tubules of diabetic rats. Hypertens Res 2003 26 413 419
38. Hollenberg NK, Fisher ND, Nussberger J, Moukarbel GV, Barkoudah E, Danser AH, Renal responses to three types of renin-Angiotensin system blockers in patients with diabetes mellitus on a high-salt diet: a need for higher doses in diabetic patients? J Hypertens 2011 29 2454 2461. doi: 10.1097/HJH.0b013e32834c627a
39. Price DA, Porter LE, Gordon M, Fisher ND, De'Oliveira JM, Laffel LM, Passan DR, Williams GH, Hollenberg NK, The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol 1999 10 2382 2391
40. Batenburg WW, Krop M, Garrelds IM, de Vries R, de Bruin RJ, Burcklé CA, Müller DN, Bader M, Nguyen G, Danser AH, Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor. J Hypertens 2007 25 2441 2453. doi: 10.1097/HJH.0b013e3282f05bae
41. Morales R, Watier Y, Böcskei Z, Human prorenin structure sheds light on a novel mechanism of its autoinhibition and on its non-proteolytic activation by the (pro)renin receptor. J Mol Biol 2012 421 100 111. doi: 10.1016/j.jmb.2012.05.003